1604 related articles for article (PubMed ID: 28652656)
81. Does Azathioprine induce endoscopic and histologic healing in pediatric inflammatory bowel disease? A prospective, observational study.
Giugliano FP; Strisciuglio C; Martinelli M; Andreozzi M; Cenni S; Campione S; D'Armiento M; Staiano A; Miele E
Dig Liver Dis; 2018 Mar; 50(3):240-246. PubMed ID: 29174208
[TBL] [Abstract][Full Text] [Related]
82. Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis.
Meckel K; Li YC; Lim J; Kocherginsky M; Weber C; Almoghrabi A; Chen X; Kaboff A; Sadiq F; Hanauer SB; Cohen RD; Kwon J; Rubin DT; Hanan I; Sakuraba A; Yen E; Bissonnette M; Pekow J
Am J Clin Nutr; 2016 Jul; 104(1):113-20. PubMed ID: 27281309
[TBL] [Abstract][Full Text] [Related]
83. Colonic mucosa-associated candida assessed by biopsy culture is associated with disease severity in ulcerative colitis: A prospective study.
Shah J; Dutta U; Rudramurthy S; Chakrabarti A; Sinha SK; Sharma V; Mandavdhare H; Sharma P; Kalsi D; Popli P; Radhika S; Das A; Kochhar R
J Dig Dis; 2019 Dec; 20(12):642-648. PubMed ID: 31626384
[TBL] [Abstract][Full Text] [Related]
84. Soluble Fc gamma receptor III (CD 16) and eicosanoid concentrations in gut lavage fluid from patients with inflammatory bowel disease: reflection of mucosal inflammation.
Hommes DW; Meenan J; de Haas M; ten Kate FJ; von dem Borne AE; Tytgat GN; van Deventer SJ
Gut; 1996 Apr; 38(4):564-7. PubMed ID: 8707088
[TBL] [Abstract][Full Text] [Related]
85. [Expression of elafin in peripheral blood in inflammatory bowel disease patients and its clinical significance].
Zhang W; Teng GG; Tian Y; Wang HH
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(14):1120-3. PubMed ID: 27095781
[TBL] [Abstract][Full Text] [Related]
86. Identification of pathologic features associated with "ulcerative colitis-like" Crohn's disease.
James SD; Wise PE; Zuluaga-Toro T; Schwartz DA; Washington MK; Shi C
World J Gastroenterol; 2014 Sep; 20(36):13139-45. PubMed ID: 25278708
[TBL] [Abstract][Full Text] [Related]
87. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
Banks C; Bateman A; Payne R; Johnson P; Sheron N
J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
[TBL] [Abstract][Full Text] [Related]
88. Inflammatory bowel diseases: controversies in the use of diagnostic procedures.
Vucelic B
Dig Dis; 2009; 27(3):269-77. PubMed ID: 19786751
[TBL] [Abstract][Full Text] [Related]
89. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA
Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
[TBL] [Abstract][Full Text] [Related]
90. Neutrophil gelatinase B-associated lipocalin and matrix metalloproteinase-9 complex as a surrogate serum marker of mucosal healing in ulcerative colitis.
de Bruyn M; Arijs I; Wollants WJ; Machiels K; Van Steen K; Van Assche G; Ferrante M; Rutgeerts P; Vermeire S; Opdenakker G
Inflamm Bowel Dis; 2014 Jul; 20(7):1198-207. PubMed ID: 24871805
[TBL] [Abstract][Full Text] [Related]
91. Interleukin 27 is up-regulated in patients with active inflammatory bowel disease.
Furuzawa Carballeda J; Fonseca Camarillo G; Yamamoto-Furusho JK
Immunol Res; 2016 Aug; 64(4):901-7. PubMed ID: 27221243
[TBL] [Abstract][Full Text] [Related]
92. Mucosal proinflammatory cytokine production correlates with endoscopic activity of ulcerative colitis.
Ishiguro Y
J Gastroenterol; 1999 Feb; 34(1):66-74. PubMed ID: 10204613
[TBL] [Abstract][Full Text] [Related]
93. Development and Validation of a Confocal Laser Endomicroscopy-Based Score for In Vivo Assessment of Mucosal Healing in Ulcerative Colitis Patients.
Hundorfean G; Chiriac MT; Mihai S; Hartmann A; Mudter J; Neurath MF
Inflamm Bowel Dis; 2017 Dec; 24(1):35-44. PubMed ID: 29272480
[TBL] [Abstract][Full Text] [Related]
94. Fibrosis Mediators in the Colonic Mucosa of Acute and Healed Ulcerative Colitis.
Gundersen MD; Goll R; Fenton CG; Anderssen E; Sørbye SW; Florholmen JR; Paulssen RH
Clin Transl Gastroenterol; 2019 Oct; 10(10):e00082. PubMed ID: 31584460
[TBL] [Abstract][Full Text] [Related]
95. [Inflammatory bowel disease in children--an analysis of the clinical symptoms and selected biochemical parameters].
Landowski P; Liberek A; Szlagatys-Sidorkiewicz A; Radys W; Brodzicki J; Szarszewski A; Marek A; Łuczak G; Kamińska B
Med Wieku Rozwoj; 2007; 11(4):401-7. PubMed ID: 18605192
[TBL] [Abstract][Full Text] [Related]
96. Correlation of Biomarker Expression in Colonic Mucosa with Disease Phenotype in Crohn's Disease and Ulcerative Colitis.
Bruno ME; Rogier EW; Arsenescu RI; Flomenhoft DR; Kurkjian CJ; Ellis GI; Kaetzel CS
Dig Dis Sci; 2015 Oct; 60(10):2976-84. PubMed ID: 25956706
[TBL] [Abstract][Full Text] [Related]
97. Endoscopic and Histologic Healing in Children With Inflammatory Bowel Diseases Treated With Thalidomide.
Lazzerini M; Villanacci V; Pellegrin MC; Martelossi S; Magazzù G; Pellegrino S; Lucanto MC; Barabino A; Calvi A; Arrigo S; Lionetti P; Fontana M; Zuin G; Maggiore G; Bramuzzo M; Maschio M; Salemme M; Manenti S; Lorenzi L; Decorti G; Montico M; Ventura A
Clin Gastroenterol Hepatol; 2017 Sep; 15(9):1382-1389.e1. PubMed ID: 28286192
[TBL] [Abstract][Full Text] [Related]
98. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
99. Imbalance of the interleukin 1 system in colonic mucosa--association with intestinal inflammation and interleukin 1 receptor antagonist [corrected] genotype 2.
Andus T; Daig R; Vogl D; Aschenbrenner E; Lock G; Hollerbach S; Köllinger M; Schölmerich J; Gross V
Gut; 1997 Nov; 41(5):651-7. PubMed ID: 9414973
[TBL] [Abstract][Full Text] [Related]
100. Imbalance of tissue inhibitors of metalloproteinases (TIMP) - 1 and - 4 serum levels, in patients with inflammatory bowel disease.
Kapsoritakis AN; Kapsoritaki AI; Davidi IP; Lotis VD; Manolakis AC; Mylonis PI; Theodoridou AT; Germenis AE; Potamianos SP
BMC Gastroenterol; 2008 Nov; 8():55. PubMed ID: 19036126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
